Bayer plan to launch GMO dicamba-resistant soybean in Brazil sparks pushback from some farmers

RRSoybeansExtend

A genetically modified soy seed technology from Germany’s Bayer set to launch soon in Brazil has sparked concern from some farmers who worry that other crops could be impacted by dicamba, a herbicide the biotech product is designed to tolerate.

Widely used in the United States, dicamba has been described by farmers who have applied it as a volatile product that drifts off easily. As such, it may compromise non-tolerant soybeans, growers told Reuters.

“When dicamba lands on plants that haven’t been designed to resist it, those plants struggle,” said Cayron Giacomelli, a farmer and agronomist. “Dicamba is highly harmful to materials other than Xtend,” Giacomelli said.

Bayer makes the “INTACTA 2 XTEND” seed technology, which allows the genetically modified soybeans to be treated with dicamba without being harmed. Dicamba is used to control broadleaf weeds in grain crops, according to Cornell University.

Bayer is planning to launch Xtend in Brazil in the 2021/2022 crop cycle. It said on [September 30] that Xtend combines biotechnology with new crop protection tools to boost farmer yields “to a new level.”

Read full, original article: Brazil grain growers wary of dicamba as Bayer launches new GM soy seed

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.noReviewsLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Screenshot 2026-07-22 at 1.38
Viewpoint: Are the U.S. and Europe headed towards a repudiation of agricultural biotechnology red tape?
Screenshot-2026-07-27-at-3.23.14-PM
Prioritizing AI, robotics, and nuclear energy: Trump administration is guiding research funding away from independent universities to private companies
png-terrace-Farm-asia
Europe’s tentative embrace of agricultural gene editing could revolutionize food production and health in Asia
ChatGPT-Image-May-26-2026-11_51_01-AM
Viewpoint: RFK, Jr.’s depressingly misguided (and litigator-funded) crusade against antidepressants
ChatGPT-Image-Jul-26-2026-05_35_53-PM
FDA takes up peptide therapies as hype outpaces science
ChatGPT-Image-Jul-26-2026-05_58_17-PM
Louisiana and Texas bring RFK,Jr.- MAHA-backed restrictions on dyes and other ‘controversial’ ingredients to eight states
Screenshot 2026-07-27 at 6.15
No test, no tennis: Women’s Tennis Association becomes first major female sports league to require genetic sex testing
ChatGPT-Image-Jul-10-2026-09_42_12-AM-1
Peptides, patient autonomy, and the limits of medical freedom
ChatGPT-Image-Jul-22-2026-09_13_07-AM
Viewpoint—The Strategic Litigation boom: Understanding the tightening coalition among NGOs, foundations, journalists, and tort lawyers
organic scaled
Facts & Fallacies podcast: Organic food cuts pesticide exposure? A response to Dr. Rhonda Patrick
ChatGPT-Image-Jul-9-2026-11_33_49-AM
Viewpoint: High-dose resveratrol supplements to extend health and life? Don’t waste your money.
Screenshot-2026-07-23-at-11.58.47-AM
Viewpoint: ‘Thought police in the UK?’ Conservatives lash out at government report calling anti-LGBQT+ narratives ‘false and misleading’
ChatGPT-Image-Jun-25-2026-12_23_17-PM
No, Bill Gates did not secretly engineer ticks to promote veganism
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.